Inventor · disambiguated record
Unmesh Shah
Also filed as: SHAH UNMESH · SHAH UNMESH G
16 granted patents·3 pending applications·82 citations·filing 2002–2020
91Inventor score
Files withSCHERING CORP6BOYLE CRAIG D5MERCK SHARP & DOHME5CHACKALAMANNIL SAMUEL1NEELAMKAVIL SANTHOSH FRANCIS1
Top patents by PatentIndex Score
19 records- 0187US6897217B22-Alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonistsSCHERING CORP·Filed 2004·Granted May 24, 2005·25 cites·21 claims
- 0284US8987195B2HCV NS3 protease inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Mar 24, 2015·9 cites·27 claims
- 0384US7572802B27-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-yl)-1-piperazinyl]ethyl]-2-(1-propynyl)-7H-pyrazolo-[4,3-e]-[1,2,4]-triazolo-[1,5-C]-pyrimidin-5-amineSCHERING CORP·Filed 2006·Granted Aug 11, 2009·7 cites·15 claims
- 0482US6916811B2Adenosine A2a receptor antagonistsSCHERING CORP·Filed 2002·Granted Jul 12, 2005·17 cites·9 claims
- 0581US9328138B2HCV NS3 protease inhibitorsMERCK SHARP & DOHME·Filed 2012·Granted May 3, 2016·8 cites·17 claims
- 0680US7368449B22-alkynyl- and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonistsSCHERING CORP·Filed 2005·Granted May 6, 2008·4 cites·16 claims
- 0778US7465740B22-heteroaryl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonistsSCHERING CORP·Filed 2006·Granted Dec 16, 2008·3 cites·17 claims
- 0876US8318751B2Pyrimidinone derivatives and methods of use thereofBOYLE CRAIG D·Filed 2008·Granted Nov 27, 2012·3 cites·42 claims
- 0975US8389532B27-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-yl)-1-piperazinyl]ethyl]-2-(1-propynyl)-7H-pyrazolo-[4,3-E]-[1,2,4]-triazolo-[1,5-C]-pyrimidin-5-amineBOYLE CRAIG D·Filed 2009·Granted Mar 5, 2013·2 cites·4 claims
- 1074US7709492B2Pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonistsSCHERING CORP·Filed 2005·Granted May 4, 2010·2 cites·20 claims
- 1170US8580807B2Bicyclic piperidine and piperazine derivatives as GPCR modulators for the treatment of obesity, diabetes and other metabolic disordersBOYLE CRAIG D·Filed 2010·Granted Nov 12, 2013·2 cites·17 claims
- 1262US11161819B2Substituted tetrahydroisoquinoline compounds useful as GPR120 agonistsMERCK SHARP & DOHME·Filed 2020·Granted Nov 2, 2021·0 cites·17 claims
- 1354US2019161448A1Substituted tetrahydroisoquinoline compounds useful as gpr120 agonistsMERCK SHARP & DOHME·Filed 2017·Application pending·0 cites
- 1448US8466149B26-substituted sulfonyl azabicyclo[3.2.1]octanes useful to inhibit 11β-hydroxysteroid dehydrogenase type-IBOYLE CRAIG D·Filed 2008·Granted Jun 18, 2013·0 cites·4 claims
- 1548US2010190687A1Pyrimidinone derivatives and methods of use thereofBOYLE CRAIG D·Filed 2008·Application pending·0 cites
- 1646US8604195B2Substituted bicyclic piperidinyl- and piperazinyl-sulfonamides useful to inhibit 11β-hydroxysteroid dehydrogenase type-1SHAH UNMESH·Filed 2008·Granted Dec 10, 2013·0 cites·2 claims
- 1742US9708270B2Substituted spiropiperidinyl compounds useful as GPR120 agonistsMERCK SHARP & DOHME·Filed 2013·Granted Jul 18, 2017·0 cites·10 claims
- 1835US8987242B2Morpholinone compounds as factor IXA inhibitorsCHACKALAMANNIL SAMUEL·Filed 2010·Granted Mar 24, 2015·0 cites·9 claims
- 1933US2012040975A1Bridged bicyclic heterocycle derivatives and methods of use thereofNEELAMKAVIL SANTHOSH FRANCIS·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Unmesh Shah files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →